Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology

Building Your Care Team and Monitoring

At a Glance

APS-1 (APECED) requires coordinated monitoring because it can affect hormone-producing glands, immune defenses, and several other organs. An endocrinologist-led team can tailor lab tests, imaging, and oral checks to a patient’s age, genetics, symptoms, and established organ involvement.

Because APS-1 (APECED) can affect many different organ systems, you cannot rely on a single doctor for all your care. Managing this condition requires a multidisciplinary team—a group of specialists who coordinate their efforts to monitor your existing issues and catch new ones [1][2]. Your team is often led by an endocrinologist with experience in rare autoimmune diseases who can act as the “quarterback” for your medical journey [1].

Your Core Care Team

Depending on your specific symptoms, your personalized care team for APS-1 may include:

  • Endocrinologist: Manages hormone replacements (adrenal, parathyroid, thyroid, and gonadal) and monitors for new deficiencies [2].
  • Immunologist or Infectious Disease Specialist: Focuses on managing Chronic Mucocutaneous Candidiasis (CMC) and protecting you from severe infections [3][4].
  • Dentist or Oral Medicine Specialist: Provides care for enamel defects and performs clinical oral evaluations [5][6].
  • Pulmonologist: Evaluates lung symptoms and monitors for lung inflammation (pneumonitis) [7].
  • Gastroenterologist/Hepatologist: Tracks gut health (malabsorption) and liver function [8][9].
  • Nephrologist: Monitors kidney health, especially if you are taking calcium and active vitamin D for hypoparathyroidism [10].

Individualized Surveillance

There is no single “one-size-fits-all” testing schedule for APS-1. Because patients experience wildly different symptoms, surveillance must be tailored to your age, genetics, and established organ involvement [11]. Rather than blanket testing, your clinical team will establish a plan based on the following areas [2][11]:

1. Endocrine and Lab Monitoring

  • Calcium and Electrolytes: Checked periodically to ensure your blood calcium levels are safe and your kidneys are not being burdened by too much urinary calcium [12][10].
  • Adrenal Function: Monitoring via symptoms, blood pressure, and electrolytes to ensure adrenal replacement (if needed) is sufficient [13].
  • Thyroid and Gonadal Health: Routine clinical review and appropriate lab testing based on age, pubertal status, or symptoms of hormone failure [4][14].
  • Liver Enzymes: Blood tests (AST/ALT/Bilirubin) to screen for autoimmune hepatitis, ordered according to specialist guidance [8].

2. Organ-Specific Evaluation

  • Lung Function: If you develop a persistent cough, shortness of breath, or reduced exercise tolerance, your team may order pulmonary function tests or chest imaging (like a CT scan) [7][15].
  • Renal Ultrasound: Used as directed by your physician to check for kidney stones or calcium deposits (nephrocalcinosis), particularly if you are treated for hypoparathyroidism [10].

3. Oral and Esophageal Surveillance

A known risk in APS-1 is the development of Squamous Cell Carcinoma (SCC) in the mouth or esophagus, linked to long-standing inflammation from chronic yeast infections [16].

  • What to Do: Regular dental or oral assessments by a clinician familiar with APECED are highly recommended [16]. Routine biopsies or endoscopies are not automatic for everyone, but any persistent white patches, sores that won’t heal, or new difficulty swallowing (dysphagia) must be evaluated promptly by your team [16][17].

By building a proactive, informed team and sticking to a consistent, individualized monitoring plan, you can manage the complexities of APS-1 and maintain the best possible quality of life [2][18].

Common questions in this guide

Why does APS-1 require a team of specialists?
APS-1 can affect hormone-producing glands, immune defenses, the mouth, lungs, digestive tract, liver, and kidneys. An endocrinologist and other specialists can coordinate care so existing problems are managed and new organ involvement is identified promptly.
Who usually leads care for someone with APS-1?
An endocrinologist experienced in rare autoimmune diseases often serves as the lead clinician. They may coordinate with immunology or infectious disease, dental or oral medicine, lung, digestive and liver, and kidney specialists.
How often should APS-1 monitoring tests be done?
There is no single monitoring schedule for everyone with APS-1. The care team should tailor follow-up to the person’s age, genetics, symptoms, and organs already affected, then adjust the plan as health changes.
What tests might be part of an APS-1 monitoring plan?
Depending on a person’s health, monitoring may include calcium and electrolyte levels, adrenal, thyroid, and gonadal assessments, liver enzymes, and kidney checks such as urinary calcium. Persistent lung symptoms may lead to lung function tests or chest imaging, and a kidney ultrasound may be used when needed.
What mouth or swallowing changes should prompt an APS-1 evaluation?
Regular dental or oral assessments are important because long-standing oral yeast infection and inflammation are linked with a higher risk of squamous cell carcinoma in the mouth or esophagus. A persistent white patch, sore that does not heal, or new difficulty swallowing should be assessed promptly; routine biopsies or endoscopies are not automatically needed for everyone.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who is the 'lead' clinician coordinating my multidisciplinary team, and how do they communicate with my other specialists?
  2. 2.How many other patients with APS-1 (APECED) have you treated, and are you familiar with the non-endocrine signs like pneumonitis or enteritis?
  3. 3.Can we establish an individualized 'surveillance calendar' that lists exactly which tests I need based on my specific risks?
  4. 4.Who should perform my comprehensive oral exams, and what is the plan if a persistent lesion is found?
  5. 5.Are my liver enzymes and kidney function (including urinary calcium) being tracked consistently to catch 'silent' inflammation early?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Approach to the patient with APS-1/APECED.

    Webb T, Pechacek J, Lionakis MS

    The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag282.

    PMID: 42460781
  2. 2

    Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED): Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, and Management.

    Hamidi M, Kamrani M, Karami S, et al.

    Endocrine, metabolic & immune disorders drug targets 2026; doi:10.2174/0118715303511788260918112249.

    PMID: 42786839
  3. 3

    Infections in the monogenic autoimmune syndrome APECED.

    Oikonomou V, Break TJ, Gaffen SL, et al.

    Current opinion in immunology 2021; (72()):286-297 doi:10.1016/j.coi.2021.07.011.

    PMID: 34418591
  4. 4

    A Patient With AIRE Mutation Who Presented With Severe Diarrhea and Lung Abscess.

    Soyak Aytekin E, Serin O, Cagdas D, et al.

    The Pediatric infectious disease journal 2021; (40(1)):66-69 doi:10.1097/INF.0000000000002887.

    PMID: 33284251
  5. 5

    Case Report: Dental Findings Can Aid in Early Diagnosis of APECED Syndrome.

    Brenchley L, Ferré EMN, Schmitt MM, et al.

    Frontiers in dental medicine 2021; (2()) doi:10.3389/fdmed.2021.670624.

    PMID: 38148990
  6. 6

    A Rare Case of Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy Syndrome: Dental Perspective on Diagnosis and Management.

    Tyagi R, Kalra N, Khatri A, et al.

    International journal of clinical pediatric dentistry 2023; (16(1)):139-146 doi:10.5005/jp-journals-10005-2496.

    PMID: 37020766
  7. 7

    Fatal autoimmune pneumonitis requiring bilobectomy and omental flap repair in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

    Kubala SA, Do HM, Ferré EMN, et al.

    Respiratory medicine case reports 2021; (33()):101476 doi:10.1016/j.rmcr.2021.101476.

    PMID: 34401309
  8. 8

    APECED-Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort.

    Chascsa DM, Ferré EMN, Hadjiyannis Y, et al.

    Hepatology (Baltimore, Md.) 2021; (73(3)):1088-1104 doi:10.1002/hep.31421.

    PMID: 32557834
  9. 9

    Serotonin and tryptophan metabolites, autoantibodies and gut microbiome in APECED.

    Naskali E, Dettmer K, Oefner PJ, et al.

    Endocrine connections 2019; (8(1)):69-77.

    PMID: 30608907
  10. 10

    Renal disorders in Autoimmune Polyendocrinopathy Candidiasis Ectodermal dystrophy (APECED): a systematic review.

    Shafiei M, Hosseini S, Ghadimi S, et al.

    BMC pediatrics 2025; (25(1)):139 doi:10.1186/s12887-025-05458-2.

    PMID: 40000975
  11. 11

    APECED and the place of AIRE in the puzzle of the immune network associated with autoimmunity.

    Aytekin ES, Cagdas D

    Scandinavian journal of immunology 2023; (98(2)):e13299 doi:10.1111/sji.13299.

    PMID: 38441333
  12. 12

    Impact of periprocedural subcutaneous parathyroid hormone on control of hypocalcaemia in APS-1/APECED patients undergoing invasive procedures.

    Winer KK, Schmitt MM, Ferre EMN, et al.

    Clinical endocrinology 2021; (94(3)):377-383 doi:10.1111/cen.14335.

    PMID: 32955743
  13. 13

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  14. 14

    Pubertal development and premature ovarian insufficiency in patients with APECED.

    Saari V, Holopainen E, Mäkitie O, Laakso S

    European journal of endocrinology 2020; (183(5)):513-520.

    PMID: 33107435
  15. 15

    Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

    Ferré EMN, Break TJ, Burbelo PD, et al.

    Science translational medicine 2019; (11(495)) doi:10.1126/scitranslmed.aav5597.

    PMID: 31167928
  16. 16

    Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED): A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes.

    Tarle M, Raguž M, Lukšić I

    International journal of molecular sciences 2025; (26(18)) doi:10.3390/ijms26188969.

    PMID: 41009535
  17. 17

    Oral Tongue Malignancies in Autoimmune Polyendocrine Syndrome Type 1.

    Bruserud Ø, Costea DE, Laakso S, et al.

    Frontiers in endocrinology 2018; (9()):463 doi:10.3389/fendo.2018.00463.

    PMID: 30177913
  18. 18

    Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

    Ferré EMN, Schmitt MM, Lionakis MS

    Frontiers in pediatrics 2021; (9()):723532 doi:10.3389/fped.2021.723532.

    PMID: 34790633

This page explains APS-1/APECED care coordination and monitoring for informational purposes only and does not constitute medical advice. Your endocrinologist and other specialists should tailor testing and follow-up to your health.

Get notified when new evidence is published on Autoimmune polyendocrinopathy type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.